Hostname: page-component-cd9895bd7-gxg78 Total loading time: 0 Render date: 2024-12-19T03:36:03.153Z Has data issue: false hasContentIssue false

GPs’ perceptions of the management of ADHD in primary care: a study of Wandsworth GPs

Published online by Cambridge University Press:  31 October 2006

Nicola Salt
Affiliation:
Battersea Research Group, Bolingbroke Hospital, Wakehurst Road, London, UK
Edward Parkes
Affiliation:
Battersea Research Group, Bolingbroke Hospital, Wakehurst Road, London, UK
Amy Scammell
Affiliation:
Battersea Research Group, Bolingbroke Hospital, Wakehurst Road, London, UK
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Attention-deficit hyperactivity disorder (ADHD) is a growing diagnosis in child mental health in the UK and is increasingly being treated with methylphenidate (Ritalin, Equasym, Concerta). There are, however, clinical and public controversies over the diagnosis and ‘labelling’ of ADHD as a disorder, the use of drug treatments, and a relative paucity of guidance on the initial diagnosis and referral of the disorder. General practitioners (GPs) are involved in the assessment, diagnosis and treatment of children with ADHD and in liasing with the other parties involved, such as parents, teachers and specialists. Therefore their understanding of ADHD and its treatment is important. This study explores Wandsworth (South West London) GPs‘ understanding of ADHD as a disorder and their views of its management in order to provide more precise detail about the issues concerning the management of ADHD in primary care by GPs.

Qualitative information was collected by semi-structured interviews (with 13 GPs) and quantitative information by means of questionnaires (93 completed by GPs) in Wandsworth.

Whilst GPs had differing views of the aetiology of ADHD, there was a consensus view about the division of responsibility in the treatment of those diagnosed with ADHD. GPs felt uncomfortable initiating the prescribing of methylphenidate and stressed the importance of ongoing specialist involvement in the management of ADHD. There was also a feeling of inadequacy in terms of the training that GPs had received.

It is suggested that guidance on the initial diagnosis of ADHD is drafted for GPs and that shared care protocols are agreed between primary care and secondary care so that the ongoing division of labour in the management of ADHD is made explicit, ensuring continuity of care.

Type
Original Article
Copyright
2005 Arnold